Velesco Pharma brings expertise to 1) Formulation of novel solutions for non-clinical and clinical formulations, 2) Analytical methods developed by a team with proven problem solving capabilities and 3) Early phase cGMP Clinical Trial Materials with capabilities across non-sterile dosage forms. Velesco offers personalized project management and expert advice to ensure the best chance of success in clinical trials. We collaborate with clients developing a customized plan to efficiently bring compounds through preclinical development into the clinic.
James E. Gregory, UPM Pharmaceuticals||October 7, 2015 Pharmaceutical and biopharmaceutical companies large and small are increasingly relying on third-party providers for support at all stages of drug development. To realize efficiencies, they are at the same time reducing the number of suppliers to a preferred few with whom they can form strategic partnerships.
Franklin Spriggs, Stephanie Mowery and Bo Kowalcyk, AIT Bioscience ||October 7, 2015 ADCs are a breakthrough cancer treatment that can deliver cytotoxins directly to cancer cells without the sweeping collateral damage of traditional chemotherapy.
Suhasini Sharma, Sciformix Corporation ||September 11, 2015 Global biologics market will expand to $250 billion annually by 2020, with biosimilars and non-original biologics commanding 4-10% of that market